Peter DeMuth

CIK: 0001979163

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ELTX

Elicio Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

ELTX
Elicio Therapeutics, Inc.
Jul 16, 2026
Award(A)
Stock Option (Right to Buy)
Direct
52.8K shares-
ELTX
Elicio Therapeutics, Inc.
Feb 2, 2026
Award(A)
Direct
20.8K shares-
ELTX
Elicio Therapeutics, Inc.
Dec 9, 2025
Exercise(M)
Direct
362 shares at avg. $4.41$2K
ELTX
Elicio Therapeutics, Inc.
Feb 3, 2025
Award(A)
Stock Option (Right to Buy)
Direct
44.4K shares-
ELTX
Elicio Therapeutics, Inc.
Dec 16, 2024
Exercise(M)
Direct
381 shares at avg. $4.41$2K
ELTX
Elicio Therapeutics, Inc.
Sep 30, 2024
Award(A)
Stock Option (Right to Buy)
Direct
29.8K shares-

		Type	Shares	Price		Ownership
Jul 16, 2026	ELTX Elicio Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	52,832	-	-	Direct
Feb 2, 2026	ELTX Elicio Therapeutics, Inc.	Award(A)	20,800	-	$0	Direct
Dec 9, 2025	ELTX Elicio Therapeutics, Inc.	Exercise(M)	362	$4.41	$1,596	Direct
Feb 3, 2025	ELTX Elicio Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	44,400	-	-	Direct
Dec 16, 2024	ELTX Elicio Therapeutics, Inc.	Exercise(M)	381	$4.41	$1,680	Direct
Sep 30, 2024	ELTX Elicio Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	29,800	-	-	Direct

1-6 of 6 transactions

About DeMuth Peter

DeMuth Peter (SEC CIK 0001979163) files insider reports with the SEC as Chief Scientific Officer of Elicio Therapeutics, Inc. (ELTX).

Signal8 holds 6 ownership filings by DeMuth Peter, all Form 4s, filed between Oct 2, 2024 and Jul 17, 2026. Those filings report 6 transactions, from Sep 30, 2024 to Jul 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on DeMuth Peter's filings is in BOSTON, MA.

Recent filings by DeMuth Peter

Jul 16, 2026: Grant or award of ELTX derivative securities (Form 4, code A).
Feb 2, 2026: Grant or award of ELTX shares (Form 4, code A).
Dec 9, 2025: Option exercise of ELTX shares (Form 4, code M).
Feb 3, 2025: Grant or award of ELTX derivative securities (Form 4, code A).
Dec 16, 2024: Option exercise of ELTX shares (Form 4, code M).

Other insiders filing for Elicio Therapeutics, Inc. (ELTX)

ADAMS JULIAN, Director
Ashe Carol Gail, Director
Chudnovsky Yekaterina, Director
Nissenson Allen, Director
RUFFOLO ROBERT R, Director
WILSON KAREN J, Director

How to read Form 4 transaction codes